Clinical Trial Update: Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial of Advair (fluticasone propionate/salmeterol) in asthmatic subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2009-09-02